Statement Of Financial Position [Abstract]

Pharming Group N.V. - Filing #2154299

Concept	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	—	—	—	9,689,000 USD	—	10,392,000 USD	—	—	—	—	—	—	—	—	—
Right-of-use assets	—	—	—	23,777,000 USD	—	28,753,000 USD	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	—	—	—	71,267,000 USD	—	75,121,000 USD	—	—	—	—	—	—	—	—	—
Investments accounted for using equity method	—	—	—	2,285,000 USD	—	2,501,000 USD	—	—	—	—	—	—	—	—	—
Deferred tax assets	—	—	—	29,761,000 USD	—	22,973,000 USD	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	—	—	—	61,741,000 USD	—	207,342,000 USD	—	—	—	—	191,924,000 USD	—	—	—	—
Assets	—	—	—	462,854,000 USD	—	425,797,000 USD	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	—	7,669,000 USD	—	7,509,000 USD	—	—	—	—	—	—	—	—	—
Retained earnings	—	—	—	265,262,000 USD	—	256,431,000 USD	—	—	—	—	—	—	—	—	—
Share premium	—	—	—	478,431,000 USD	—	462,297,000 USD	—	—	—	—	—	—	—	—	—
Other reserves	—	—	—	2,057,000 USD	—	8,737,000 USD	—	—	—	—	—	—	—	—	—
Equity	478,431,000 USD	7,669,000 USD	265,262,000 USD	218,781,000 USD	2,057,000 USD	204,638,000 USD	462,297,000 USD	256,431,000 USD	7,509,000 USD	8,737,000 USD	192,916,000 USD	273,167,000 USD	3,400,000 USD	455,254,000 USD	7,429,000 USD
Equity and liabilities	—	—	—	462,854,000 USD	—	425,797,000 USD	—	—	—	—	—	—	—	—	—